Monday, 17 December 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) wishes to provide an update on the Company’s CEO transition.
Further to the announcement on 27 September 2018 regarding the intended departure of AusCann’s Managing Director, Ms Elaine Darby, the Company advises the executive CEO search is progressing to plan and is now at an advanced stage. The Board has selected a final shortlist and is confident in the high calibre of Australian and international candidates that it believes have the necessary skills and experience to guide AusCann through its next phase of growth as a pharmaceutical manufacturing and sales business. The Board expects to make an appointment once final interviews have been completed early in the new year.
For further information please download PDF attached:
Download this document
